Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
US SEC removes legal obstacle to UBS’ crisis-resolution plan
WASHINGTON, July 8 (Reuters) – The U.S. Securities and Exchange Commission told UBS Group [RIC:RIC:UBSAG.UL] on Wednesday that…
Swiss poised to issue UBS capital rules that could alter bank’s future
Item 1 of 3 A logo of Swiss bank UBS on a building at the Paradeplatz in Zurich,…
US FDA approves Novartis’ gene therapy for rare muscle disorder
Item 1 of 3 The company’s logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz,…